Ignite Creation Date:
2024-05-06 @ 7:55 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02632045
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-06
First Post:
2015-12-14
Brief Title:
Study of Efficacy of Ribociclib After Progression on CDK46 Inhibition in Patients With HR HER2- Advanced Breast Cancer
Sponsor:
Melissa K Accordino
Organization:
Columbia University
Organization Data
Organization:
Columbia University
Class:
OTHER
Study ID:
AAAP9506
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Melissa K Accordino
Lead Sponsor Class:
OTHER
Responsible Party:
Melissa K Accordino
Responsible Party Title:
Assistant Professor of Medicine Division of HematologyOncology
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Columbia University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |